Lei Tuo

454 total citations
12 papers, 372 citations indexed

About

Lei Tuo is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Lei Tuo has authored 12 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Lei Tuo's work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers) and Circular RNAs in diseases (3 papers). Lei Tuo is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers) and Circular RNAs in diseases (3 papers). Lei Tuo collaborates with scholars based in China and United States. Lei Tuo's co-authors include Xiufeng Cao, Qingquan Wu, Suqing Li, Weihong Shi, Yu‐Suo Tong, Chunmei Wang, Fangjun Chen, LV Ji, Jin Lv and Ming Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, AAPG Bulletin and Digestive Diseases and Sciences.

In The Last Decade

Lei Tuo

12 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lei Tuo China 9 287 286 47 30 28 12 372
Da Jiang China 11 88 0.3× 175 0.6× 37 0.8× 38 1.3× 30 1.1× 37 380
Xiaohan Dong China 12 153 0.5× 205 0.7× 11 0.2× 3 0.1× 20 0.7× 28 413
Luyuan Huang China 10 66 0.2× 120 0.4× 11 0.2× 27 0.9× 5 0.2× 30 296
Jialu Zhu China 11 350 1.2× 439 1.5× 26 0.6× 9 0.3× 12 0.4× 18 575
Miaoyun Qiu China 9 331 1.2× 429 1.5× 23 0.5× 9 0.3× 9 0.3× 13 554
Mo‐qi Lv China 11 289 1.0× 351 1.2× 9 0.2× 10 0.3× 22 0.8× 26 565
Haitao Wei China 9 259 0.9× 274 1.0× 19 0.4× 6 0.2× 19 0.7× 18 329
Xianren Ye China 11 31 0.1× 40 0.1× 25 0.5× 28 0.9× 6 0.2× 24 342
Qiuhan Hua China 13 497 1.7× 551 1.9× 29 0.6× 2 0.1× 50 1.8× 23 667

Countries citing papers authored by Lei Tuo

Since Specialization
Citations

This map shows the geographic impact of Lei Tuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Tuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Tuo more than expected).

Fields of papers citing papers by Lei Tuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Tuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Tuo. The network helps show where Lei Tuo may publish in the future.

Co-authorship network of co-authors of Lei Tuo

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Tuo. A scholar is included among the top collaborators of Lei Tuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Tuo. Lei Tuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Tuo, Lei, Weidong Bing, Qingxi Qu, et al.. (2022). Prostaglandin E1 reduces apoptosis and improves the homing of mesenchymal stem cells in pulmonary arterial hypertension by regulating hypoxia-inducible factor 1 alpha. Stem Cell Research & Therapy. 13(1). 316–316. 19 indexed citations
3.
Chen, Xuegang, et al.. (2020). Diagenetic differences caused by gas charging with different compositions in the XF13 block of the Yinggehai Basin, South China Sea. AAPG Bulletin. 104(4). 735–765. 12 indexed citations
4.
Tuo, Lei, et al.. (2019). Spontaneous cerebrospinal fluid rhinorrhea associated with an incidental pituitary adenoma. British Journal of Neurosurgery. 37(4). 956–959. 3 indexed citations
5.
Tuo, Lei, et al.. (2018). [MicroRNA and Lung Cancer: A Mini Review].. SHILAP Revista de lepidopterología. 21(9). 727–730. 5 indexed citations
6.
Zhu, Yangming, et al.. (2018). Geochemical composition and origin of Tertiary oils in the Yinggehai and Qiongdongnan Basins, offshore South China Sea. Marine and Petroleum Geology. 96. 139–153. 26 indexed citations
7.
Tuo, Lei, et al.. (2018). P16INK4a gene promoter methylation as a biomarker for the diagnosis of non‐small cell lung cancer: An updated meta‐analysis. Thoracic Cancer. 9(8). 1032–1040. 19 indexed citations
8.
Shi, Weihong, Qingquan Wu, Suqing Li, et al.. (2015). Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma. Tumor Biology. 36(4). 2501–2507. 87 indexed citations
9.
Li, Suqing, Feng Li, Yun Xiao, et al.. (2014). Comparison of long non-coding RNAs, microRNAs and messenger RNAs involved in initiation and progression of esophageal squamous cell carcinoma. Molecular Medicine Reports. 10(2). 652–662. 10 indexed citations
10.
Wu, Qingquan, Bin Zhu, Fangjun Chen, et al.. (2014). Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis. Tumor Biology. 35(8). 7743–7754. 97 indexed citations
11.
Yang, Pengfei, Lei Tuo, Qingquan Wu, & Xiufeng Cao. (2014). Licochalcone-A sensitizes human esophageal carcinoma cells to TRAIL-mediated apoptosis by proteasomal degradation of XIAP.. PubMed. 61(133). 1229–34. 13 indexed citations
12.
Wang, Chunmei, Qingquan Wu, Suqing Li, et al.. (2013). Upregulation of the Long Non-coding RNA PlncRNA-1 Promotes Esophageal Squamous Carcinoma Cell Proliferation and Correlates with Advanced Clinical Stage. Digestive Diseases and Sciences. 59(3). 591–597. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026